cyclazodone cyclazodone cyclazodone is a centrally acting stimulant drug developed by american cyanamid company in the 1960s. the drug is related to other drugs such as pemoline and thozalinone. it displayed a favorable therapeutic index and margin of safety in comparison to pemoline and other n-lower-alkyl-substituted pemoline derivatives. the patents concluded that cyclazodone possessed properties efficacious in reducing fatigue and as a potential anorectic. structural congeners of pemoline have been described as "excitants with unique properties distinguishing them from the sympathomimetic amines" whilst displaying less stimulatory activity and toxicity compared to amphetamine. not to be confused with cyclexanone. cyclazodoneclinical dataroutes ofadministrationoralatc codenonelegal statuslegal status in general: legal identifiers iupac name (rs)-2-(cyclopropylamino)-5-phenyl-1,3-oxazol-4-one cas number14461-91-7 ypubchem cid26701chemspider24875 nuniio8u55zrl9kchemblchembl2106536 nchemical and physical dataformulac12h12n2o2molar mass216.240 g·mol−13d model (jsmol)interactive imagechiralityracemic mixture smiles c1cc1nc2=nc(=o)c(o2)c3=cc=cc=c3 inchi inchi=1s/c12h12n2o2/c15-11-10(8-4-2-1-3-5-8)16-12(14-11)13-9-6-7-9/h1-5,9-10h,6-7h2,(h,13,14,15) nkey:dnrktaypgadpgw-uhfffaoysa-n n ny (what is this?) (verify) it is included under the world anti-doping agency prohibited list. safety cyclazodone has not been evaluated by the united states food and drug administration for use in humans as a nootropic, anorectic, or stimulant and thus safety information on cyclazodone is lacking. however, in studies relating to the therapeutic uses of cyclazodone, it was noted that cyclazodone exhibited less cardiotoxic and hepatotoxic effects than d-amphetamine in studies on mice.